IGFBP4 and pulmonary arterial hypertension: In a different context, Torres et al. demonstrated a substantial increase in serum IGFBP4 levels in people suffering from pulmonary arterial hypertension (PAH), whereby IGFBP4 was presented as a circulating prognostic biomarker and was linked to disease severity [67].